Search research articles
Contact Us
Filters
Showing results (1-10 of 302) with videos related to
Page
of 31
Sort By:
Expert Opinion on Biological Therapy
|
December 2, 2014
Autologous stem cell transplantation in multiple myeloma is not dead but alive and well
Massimo Martino, Fortunato Morabito
Current Cancer Drug Targets
|
June 8, 2012
Targeted therapy of multiple myeloma: the changing paradigm at the beginning of the new millennium
Fortunato Morabito, Anna Grazia Recchia, Carla Mazzone, et al.
Expert Opinion on Emerging Drugs
|
August 28, 2012
Emerging biological insights and novel treatment strategies in multiple myeloma
Massimo Gentile, Anna Grazia Recchia, Carla Mazzone, et al.
Leukemia & Lymphoma
|
June 12, 2015
Ibrutinib, idelalisib and obinutuzumab for the treatment of patients with chronic lymphocytic leukemia: three new arrows aiming at the target
Fortunato Morabito, Massimo Gentile, John F Seymour, et al.
Clinical Rheumatology
|
July 1, 2005
Eosinophilic fasciitis associated with autoimmune phenomena after bone marrow transplantation: report of two cases
Paola L Minciullo, Fortunato Morabito, Rosalba Mandaglio, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
January 20, 2025
Refining High-Risk Multiple Myeloma: Advancements in Genomic, Clinical, and Prognostic Criteria
Enrica Antonia Martino, Giuseppe Mele, Ernesto Vigna, et al.
Haematologica
|
February 12, 2002
Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil
Fortunato Morabito, Massimo Mangiola, Caterina Stelitano, et al.
Leukemia & Lymphoma
|
November 17, 2006
Incidence of second neoplasia in patients with B-cell chronic lymphocytic leukemia treated with chlorambucil maintenance chemotherapy
Vincenzo Callea, Maura Brugiatelli, Caterina Stelitano, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 3, 2014
Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis
Stefano Molica, Diana Giannarelli, Luciano Levato, et al.
Expert Opinion on Investigational Drugs
|
March 22, 2016
Sorafenib for the treatment of multiple myeloma
Massimo Gentile, Massimo Martino, Anna Grazia Recchia, et al.
Page
of 31
Search research articles
Search
Showing results (1-10 of 302) with videos related to
Sort By:
Page
of 31
Expert Opinion on Biological Therapy
|
December 2, 2014
Autologous stem cell transplantation in multiple myeloma is not dead but alive and well
Massimo Martino, Fortunato Morabito
Current Cancer Drug Targets
|
June 8, 2012
Targeted therapy of multiple myeloma: the changing paradigm at the beginning of the new millennium
Fortunato Morabito, Anna Grazia Recchia, Carla Mazzone, et al.
Expert Opinion on Emerging Drugs
|
August 28, 2012
Emerging biological insights and novel treatment strategies in multiple myeloma
Massimo Gentile, Anna Grazia Recchia, Carla Mazzone, et al.
Leukemia & Lymphoma
|
June 12, 2015
Ibrutinib, idelalisib and obinutuzumab for the treatment of patients with chronic lymphocytic leukemia: three new arrows aiming at the target
Fortunato Morabito, Massimo Gentile, John F Seymour, et al.
Clinical Rheumatology
|
July 1, 2005
Eosinophilic fasciitis associated with autoimmune phenomena after bone marrow transplantation: report of two cases
Paola L Minciullo, Fortunato Morabito, Rosalba Mandaglio, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
January 20, 2025
Refining High-Risk Multiple Myeloma: Advancements in Genomic, Clinical, and Prognostic Criteria
Enrica Antonia Martino, Giuseppe Mele, Ernesto Vigna, et al.
Haematologica
|
February 12, 2002
Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil
Fortunato Morabito, Massimo Mangiola, Caterina Stelitano, et al.
Leukemia & Lymphoma
|
November 17, 2006
Incidence of second neoplasia in patients with B-cell chronic lymphocytic leukemia treated with chlorambucil maintenance chemotherapy
Vincenzo Callea, Maura Brugiatelli, Caterina Stelitano, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 3, 2014
Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis
Stefano Molica, Diana Giannarelli, Luciano Levato, et al.
Expert Opinion on Investigational Drugs
|
March 22, 2016
Sorafenib for the treatment of multiple myeloma
Massimo Gentile, Massimo Martino, Anna Grazia Recchia, et al.
Page
of 31